We are live on ! Find out more
CTIC

CTI BioPharma Corp. (DE) Common Stock
CTIC

Delisted

CTIC was delisted on the 23rd of June, 2023.

Back to rankings

64 hedge funds and large institutions have $25.9M invested in CTI BioPharma Corp. (DE) Common Stock in 2013 Q2 according to their latest regulatory filings, with 64 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $185K

Holders
64
Holders Change
+64
Holders Change %
–
% of All Funds
2.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
64
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
$185K
Net Calls
-$185K
Net Calls Change
-$185K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$6.57M +$7.33M +625,243 New
BIT
2
BlackRock Institutional Trust
California
$3.58M +$3.99M +340,507 New
BFA
3
BlackRock Fund Advisors
California
$2.95M +$3.29M +280,727 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$2.27M +$2.53M +216,112 New
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$1.09M +$1.22M +104,266 New
KCG
6
Knight Capital Group
$1.08M +$1.19M +101,938 New
Jacobs Levy Equity Management
7
Jacobs Levy Equity Management
New Jersey
$991K +$1.11M +94,367 New
BA
8
BlackRock Advisors
Delaware
$803K +$896K +76,463 New
Jane Street
9
Jane Street
New York
$649K +$725K +61,852 New
TCIM
10
TIAA CREF Investment Management
New York
$610K +$681K +58,138 New
Morgan Stanley
11
Morgan Stanley
New York
$509K +$569K +48,506 New
Northern Trust
12
Northern Trust
Illinois
$478K +$534K +45,553 New
Bank of New York Mellon
13
Bank of New York Mellon
New York
$386K +$431K +36,738 New
State Street
14
State Street
Massachusetts
$319K +$357K +30,426 New
BIM
15
BlackRock Investment Management
Delaware
$305K +$340K +29,019 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$288K +$322K +27,439 New
WT
17
Washington Trust
Rhode Island
$273K +$304K +25,966 New
ZIM
18
Zacks Investment Management
Illinois
$227K +$254K +21,637 New
California State Teachers Retirement System (CalSTRS)
19
California State Teachers Retirement System (CalSTRS)
California
$206K +$230K +19,627 New
Susquehanna International Group
20
Susquehanna International Group
Pennsylvania
$188K +$210K +17,882 New
Bank of America
21
Bank of America
North Carolina
$167K +$186K +15,909 New
Charles Schwab
22
Charles Schwab
California
$160K +$188K +16,060 New
TA
23
Teachers Advisors
New York
$150K +$167K +14,269 New
CS
24
Credit Suisse
Switzerland
$140K +$156K +13,339 New
CAS
25
CTC Alternative Strategies
Illinois
$113K +$126K +10,730 New
1
2 3

CTIC Hedge Fund Activity: Q2 2013 in Review

64 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in CTI BioPharma Corp. (DE) Common Stock (CTIC) for Q2 2013, worth a combined $25.9M.

Buyers outnumbered sellers: 64 funds opened new CTIC positions and 0 closed out — a net gain of 64 holders — while 0 added to existing stakes and 0 trimmed.

  • 64 institutional investors held CTI BioPharma Corp. (DE) Common Stock (CTIC) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $25.9M of CTI BioPharma Corp. (DE) Common Stock stock for Q2 2013.
  • 64 funds opened new CTI BioPharma Corp. (DE) Common Stock positions in Q2 2013 and 0 closed out, a net change of +64 holders.

Based on aggregated 13F filings for Q2 2013.